Autoimmune Myelopathy Profile
Use
This test can assist in the diagnosis (paraneoplastic or idiopathic autoimmune) and aid distinction from other causes of myelopathy (sarcoidosis, vascular disease, multiple sclerosis). Early testing may assist in early diagnosis of occult cancer, prompt initiation of immune therapies, or both.
Special Instructions
Autoimmune Myelopathy Profile test includes the investigation of several antibodies related to paraneoplastic and autoimmune conditions. Physicians should ensure proper specimen collection and handling to avoid delays. Additional time may be required for confirmatory or reflex tests.
Limitations
This test was developed and its performance characteristics determined by Labcorp in accordance with CLIA requirements and has not been cleared or approved by the FDA. Results should be integrated with clinical and other laboratory data when formulating a disease diagnosis. Negative results do not exclude autoimmune myelopathy, and other confirmatory tests may be required.
Methodology
Immunoassay (Immunofluorescence, EIA, Immunoblot)
Biomarkers
LOINC Codes
- 56850-1
- 49738-8
- 43187-4
- 43102-3
- 84924-0
- 84925-7
- 84926-5
- 33422-7
- 43103-1
- 47401-5
- 84927-3
- 82976-2
- 94347-2
- 84929-9
- 84930-7
- 84931-5
- 84928-1
- 94345-6
- 61430-5
- 91545-4
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Gel barrier tube, serum transfer tube
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icetrus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |